Basic Information
Basic information for NR2F1-AS1-219-32aa
Peptide Name NR2F1-AS1-219-32aa
Genome Position chr5:93409749-93409844[-]
Species Human
Peptide Sequence MWSLSSINLQLVSGYIVFLLLLIRCIPKTINT
Peptide Length 32
Unique No (NR2F1-AS1-204-32aa,NR2F1-AS1-205-32aa,NR2F1-AS1-206-32aa,NR2F1-AS1-207-32aa,NR2F1-AS1-208-32aa,NR2F1-AS1-210-32aa,NR2F1-AS1-213-32aa,NR2F1-AS1-216-32aa,NR2F1-AS1-220-32aa,NR2F1-AS1-224-32aa,NR2F1-AS1-225-32aa,NR2F1-AS1-226-32aa,NR2F1-AS1-227-32aa,NR2F1-AS1-230-32aa,NR2F1-AS1-231-32aa,NR2F1-AS1-232-32aa,NR2F1-AS1-233-32aa,NR2F1-AS1-234-32aa,NR2F1-AS1-235-32aa,NR2F1-AS1-236-32aa,NR2F1-AS1-238-32aa,NR2F1-AS1-239-32aa,NR2F1-AS1-240-32aa,NR2F1-AS1-241-32aa,NR2F1-AS1-243-32aa,NR2F1-AS1-245-32aa,NR2F1-AS1-247-32aa,NR2F1-AS1-248-32aa,NR2F1-AS1-249-32aa,NR2F1-AS1-251-32aa,NR2F1-AS1-252-32aa,NR2F1-AS1-254-32aa-1,NR2F1-AS1-255-32aa,NR2F1-AS1-256-32aa,NR2F1-AS1-257-32aa,NR2F1-AS1-258-32aa,NR2F1-AS1-259-32aa,NR2F1-AS1-260-32aa,NR2F1-AS1-261-32aa,NR2F1-AS1-262-32aa-2,NR2F1-AS1-264-32aa,NR2F1-AS1-266-32aa,NR2F1-AS1-267-32aa,NR2F1-AS1-268-32aa,NR2F1-AS1-272-32aa-2,NR2F1-AS1-273-32aa,NR2F1-AS1-274-32aa,NR2F1-AS1-275-32aa)
Grand Average of Hydropathicity 1.1562
Relative Molecular Mass 4208.97
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000237187;NR2F1-AS1
Transcript ID/Name ENST00000653325;NR2F1-AS1-219
Transcript Length 3370
Coding Ability 0.3662
DNA Sequence Corresponding to Peptide ATGTGGAGCCTGTCTTCAATAAATTTACAGTTAGTTTCAGGGTACATTGTTTTTCTTCTGCTGTTAATTAGGTGTATCCCCAAGACAATAAATACA
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :